An algorithm could be used by an NHS hospital in England to predict which people may experience a mental health crisis based on their mobile phone use, according to a press report.
A study has shown that deep learning could be used to monitor therapists’ effectiveness at conducting cognitive behavioural therapy (CBT), a favoured method for dealing with mental health p
Karuna Therapeutics has raised $68 million to further develop its neurology drug KarXT, which is in phase 2 clinical development for acute psychosis in patients with schizophrenia.
A panel of advisers to the FDA has voted in favour of approving Johnson & Johnson’s experimental nasal spray for depression, esketamine, bringing the medicine closer to approval.